Skip to content
2000
Volume 2, Issue 2
  • ISSN: 1389-2002
  • E-ISSN: 1875-5453

Abstract

Hepatic cytochrome P450 (P450) enzyme activities and gene expression can be profoundly altered in disease states. In general the levels of affected hepatic P450 enzymes are depressed by diseases, causing potential and documented impairment of drug clearance and clinical drug toxicity. However, modulation of P450s is enzyme selective and this selectivity differs among different diseases. This review will concentrate on regulation of P450s in diabetes, obesity and infectious and inflammatory disease, conditions that affect millions of people worldwide every day.

Loading

Article metrics loading...

/content/journals/cdm/10.2174/1389200013338676
2001-06-01
2025-09-21
Loading full text...

Full text loading...

/content/journals/cdm/10.2174/1389200013338676
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test